American Century Companies Inc. Sells 456,710 Shares of Cardinal Health, Inc. $CAH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. lowered its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 41.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 636,640 shares of the company's stock after selling 456,710 shares during the period. American Century Companies Inc. owned about 0.27% of Cardinal Health worth $87,710,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health in the first quarter valued at $26,000. Bellwether Advisors LLC acquired a new stake in Cardinal Health in the fourth quarter valued at $32,000. Tompkins Financial Corp lifted its stake in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health in the fourth quarter valued at $36,000. Finally, GW&K Investment Management LLC lifted its stake in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Cardinal Health stock traded down $3.5270 during midday trading on Friday, hitting $148.0430. The company's stock had a trading volume of 1,687,059 shares, compared to its average volume of 2,418,089. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44. The company has a 50-day moving average price of $159.28 and a two-hundred day moving average price of $145.17. The company has a market cap of $35.35 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 1.29 and a beta of 0.67.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the company earned $1.84 EPS. The business's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's payout ratio is 31.63%.

Insiders Place Their Bets

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is currently owned by insiders.

Analyst Ratings Changes

CAH has been the subject of a number of recent analyst reports. Bank of America increased their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Wells Fargo & Company reiterated an "overweight" rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Robert W. Baird increased their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Finally, Citigroup restated a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $163.20.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.